Skip to main content
. 2018 Feb 15;12:331–337. doi: 10.2147/OPTH.S144403

Table 1.

Demographical information, indications, and previously diagnosed comorbidities in patients receiving an aphakic Boston snap-on type I keratoprosthesis at the Bascom Palmer Eye Institute

Ocular history Group (n=45)
Demographics
Number of eyes 45
Mean age at surgery (years ± SD) 66.7±16.8
Females, n (%) 23 (51)
Right eye, n (%) 28 (62)
Prior corneal grafts
Prior failed graft, n (%) 40 (89)
Number of previously failed grafts, n ± SD 2.5±1.0
Underlying corneal pathologya
Glaucoma related, n (%) 11 (24)
Aphakic or pseudophakic bullous keratopathy, n (%) 7 (16)
Thermal/chemical burn, n (%) 4 (9)
Herpetic keratitis, n (%) 4 (9)
Uveitis, n (%) 4 (9)
Keratoconus, n (%) 2 (4)
Fuch’s endothelial dystrophy, n (%) 2 (4)
Stevens–Johnson syndrome, n (%) 2 (4)
Retinal detachment related, n (%) 2 (4)
Aniridia, n (%) 1 (2)
Corneal ulcer, n (%) 1 (2)
Corneal exposure, n (%) 1 (2)
Endophthalmitis, n (%) 1 (2)
Irido-corneal-endothelial syndrome, n (%) 1 (2)
Mooren’s ulcer, n (%) 1 (2)
Riley day syndrome, n (%) 1 (2)
Contralateral eye
No significant pathology, n (%) 6 (13)
Visually impaired/legal blindness, n (%) 26 (58)
Blind/anophthalmic, n (%) 13 (29)
Preoperative lens status
Pseudophakia, n (%) 25 (56)
Aphakia, n (%) 19 (42)
Iris status
Aniridia, n (%) 14 (31)
Ocular and surgical history
Underlying glaucoma, any type, n (%) 34 (76)
Prior glaucoma drainage implant, n (%) 25 (26)
Previous vitrectomy, n (%) 12 (27)

Note:

a

In patients with multiple ocular comorbidities, the most likely primary etiology leading to the need for KPro implantation was listed.

Abbreviations: Kpro, keratoprosthesis; n, number.